A Beckley Retreats webinar · Leadership
For people who lead at work and at home.
An educational session on what psychedelics do in the brain, what the research shows, and what it could mean for leadership—with a closer look at psilocybin, the limits of the evidence, and legal routes to access.
The brain Mechanisms and patterns
The evidence Findings and limitations
The next step Safety and legal access
Join the conversation
Join a 60-minute educational conversation about the science, the questions leaders are asking, and what responsible exploration involves.
Having trouble with the form? Open registration in a new tab.
No previous psychedelic knowledge or experience needed. Come to learn, take part in audience polls, and ask questions during the live Q&A.
What we’ll explore
You may have tried coaching, therapy, meditation, or another framework. You know how you want to handle the difficult conversation—yet under pressure, the familiar reaction returns. Or you’re performing well at work and arriving home with little left to give.
This webinar explores those questions through the science of psychedelics, with a focus on psilocybin. We’ll look at brain activity, research on wellbeing and patterns of thought, and why preparation and integration matter—while separating established findings from possibilities still being studied.
Get an accessible introduction to the different compounds, then explore psilocybin’s effects on receptors, brain networks, and neuroplasticity—and the questions these findings raise about familiar patterns of thought.
Examine research on mental health, openness, meaning, and wellbeing, including studies in healthy adults. Explore the relevance to leadership while keeping study limitations and unproven claims about performance in view.
Understand screening, risks, preparation, setting, and integration. Learn about routes to access, including clinical trials, supervised services, and legal retreats, and bring your questions to the live Q&A.
Meet your host
Co-Founder & CEO · Beckley Retreats
Neil brings experience as a U.S. Army Ranger captain, McKinsey consultant, and business leader. At McKinsey, he co-led the firm’s internal mindfulness initiative.
A certified Mindfulness-Based Stress Reduction teacher, Neil brings a personal and professional perspective on contemplative practice, psychedelics, and the work of leading others.
Before you join
No. We’ll begin with the basics, distinguish between different compounds, and explain why the conversation focuses on psilocybin. You don’t need previous knowledge or experience.
This is an educational session focused on the science, evidence, and open questions. Legal retreats will be discussed as one route to access. People who want program details can choose a separate follow-up conversation; attending this webinar does not commit you to applying for a retreat.
Yes. The one-hour session includes audience polls and a live Q&A. Bring your questions about the research, safety, preparation, integration, and legal access. Individual program questions will be directed to a separate follow-up conversation.
This is an educational conversation, not individual medical advice or a recommendation to use psychedelics. Questions about your health, treatment, or medications belong with a qualified healthcare professional. If you decide to apply for our program, we have a suitability consultation to talk about personal suitability for our program.
Research on clinical conditions and studies of wellbeing in healthy adults do not, on their own, establish improved leadership or business performance. We’ll distinguish measured findings, personal accounts, and questions that still need research.
Start with understanding
Join us to explore the science, its limits, and the questions that matter to how you lead—at work and at home.
-2-1.png){kind=logo}
